Isoniazid induces expression of the antigen 85 complex in Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 7, 1996, Pages 1754-1756

  Garbe, Thomas R ^a   Hibler, Nina S ^a   Deretic, V ^a,b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; MYCOLIC ACID;

ANTIGEN EXPRESSION; ARTICLE; DRUG METABOLISM; GEL ELECTROPHORESIS; GENE EXPRESSION; IMMUNOBLOTTING; MYCOBACTERIUM TUBERCULOSIS; NEGATIVE FEEDBACK; PRIORITY JOURNAL; REGULATORY MECHANISM;

EID: 0029902636     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.7.1754     Document Type: Article

References (26)

1. Abou-Zeid, C., T. Garbe, R. Lathigra, H. G. Wiker, M. Harboe, G. A. W. Rook, and D. B. Young. 1991. Genetic and immunological analysis of Mycobacterium tuberculosis fibronectin-binding proteins. Infect. Immun. 59:2712-2718.
2. Abou-Zeid, C., T. L. Ratliff, H. G. Wiker, M. Harboe, J. Bennedsen, and G. A. W. Rook. 1988. Characterization of fibronectin-binding antigens released by Mycobacterium tuberculosis and Mycabacterium bovis BCG. Infect. Immun. 56:3046-3051.
3. Andersen, Å. B., Z. I. Yuan, K. Hasløv, B. Vermann, and J. Bennedsen. 1986. Interspecies reactivity of five monoclonal antibodies to Mycobacterium tuberculosis as examined by immunoblotting and enzyme-linked immunosorbent assay. J. Clin. Microbiol. 23:446-451.
4. Andersen, P., D. Askgaard, L. Ljungqvist, J. Bennedsen, and I. Heron. 1991. Proteins released from Mycobacterium tuberculosis during growth. Infect. Immun. 59:1905-1910.
5. Banerjee, A., E. Dubnau, A. Quemard, V. Balasubramanian, K. Sun Um, T. Wilson, D. Collins, G. de Lisle, and W. R. Jacobs, Jr. 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263:227-230.
6. Belisle, J. T., T. Sievert, K. Takayama, and G. S. Besra. 1995. Identification of a mycolyltransferase from Mvcobacterium tuberculosis and the coincident definition of the physiological function of antigen 85B, p. 212-216. In Program of the 30th Joint Conference on Tuberculosis and Leprosy, US-Japan Cooperative Medical Science Program. National Institute of Allergy and Infectious Diseases, Bethesda, Md.
7. Bloom, B. R., and C. J. L. Murray. 1992. Tuberculosis: commentary on a reemergent killer. Science 257:1055-1064.
8. Borremans, M., L. De Wit, G. Volckaert, J. Ooms, J. De Bruyn, K. Huygen, J.-P. Van Vooren, M. Stelandre, R. Verhofstadt, and J. Content. 1989. Cloning, sequence determination, and expression of a 32-kilodalton-protein gene of Mycobacterium tuberculosis. Infect. Immun. 57:3123-3130.
9. Bravo, R. 1984. Two dimensional gel electrophoresis: a guide to beginners, p. 3-36. In J. E. Celis and R. Bravo (ed.), Two dimensional gel electrophoresis of proteins. Academic Press, Orlando, Fla.
10. Content, J., A. de la Cuvellerie, L. De Wit, V. Vincent-Levy-Frébault, J. Ooms, and J. De Bruyn. 1991. The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning, sequence determination, and genomic organization of the gene coding for antigen 85-C of M. tuberculosis. Infect. Immun. 59:3205-3212.
11. Deretic, V., W. Philipp, S. Dhandayuthapani, M. H. Mudd, R. Curcic, T. Garbe, B. Heym, L. E. Via, and S. T. Cole. 1995. Mycobacterium tuberculosis is a natural mutant with inactivated oxidative stress regulatory gene: implications for sensitivity to isoniazid. Mol. Microbiol. 17:889-900.
12. Dessen, A., A. Quemard, J. S. Blanchard, W. R. Jacobs, and J. C. Sacchettini. 1995. Crystal structure and function of the isoniazid target of Mycobaclerium tuberculosis. Science 267:1638-1641.
13. De Wit, L., M. Palou, and J. Content. 1994. Nucleotide sequence of the 85B-protein gene of Mycobacterium bovis BCG and Mycobaclerium tuberculosis. DNA Seq. 4:267-270.
14. Garbe, T. R., N. S. Hibler, and V. Deretic. 1996. Response of Mycobacterium tuberculosis to reactive oxygen and nitrogen intermediates. Mol. Med. 2:134-142.
15. Heym, B., Y. Zhang, S. Poulet, D. Young, and S. T. Cole. 1993. Characterization of the katG gene encoding a catalase-peroxidase required for the isoniazid susceptibility of Mycobacterium tuberculosis. J. Bacteriol. 175:4255-4259.
16. Horwitz, M. A., B. W. Lee, B. J. Dillon, and G. Harth. 1995. Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. USA 92: 1530-1534.
17. Kremer, L., A. Baulard, J. Estaquier, J. Content, A. Capron, and C. Locht. 1995. Analysis of the Mycobacterium tuberculosis 85A antigen promoter region. J. Bacteriol. 177:642-653.
18. Quemard, A., G. Lanéelle, and C. Lacave. 1992. Mycolic acid synthesis: a target for ethionamide in mycobacteria? Antimicrob. Agents Chemother. 36:1316-1321.
19. Quemard, A., J. C. Sacchettini, A. Dessen, C. Vilcheze, R. Bittman, W. R. Jacobs, and J. S. Blanchard. 1995. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. Biochemistry 34:8235-8241.
20. Sathyamoorthy, N., and K. Takayama. 1987. Purification and characterization of a novel mycolic acid exchange enzyme from Mycobacterium smegmatis. J. Biol. Chem. 262:13417-13423.
21. Wiker, H. G., and M. Harboe. 1992. The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis. Microbiol. Rev. 56:648-661.
22. Wiker, H. G., S. Nagai, M. Harboe, and L. Ljungqvist. 1992. A family of cross-reacting proteins secreted by Mycobacterium tuberculosis. Scand. J. Immunol. 36:307-319.
23. Winder, F. G. 1982. Mode of action of the antimycobacterial agents and associated aspects of the molecular biology of mycobacteria, p. 353-438. In C. Ratledge and J. Stanford (ed.), The biology of the mycobacteria. Academic Press, New York.
24. Young, D. B., and T. R. Garbe. 1991. Heat shock proteins and antigens of Mycobacterium tuberculosis. Infect. Immun. 59:3086-3093.
25. Zhang, Y., T. Garbe, and D. Young. 1993. Transformation with katG restores isoniazid-sensitivity in Mycobacterium tuberculosis isolates resistant to a range of drug concentrations. Mol. Microbiol. 8:521-524.
26. Zhang, Y., and D. B. Young. 1993. Molecular mechanisms of isoniazid: a drug at the front line of tuberculosis control. Trends Microbiol. 1:109-113.